Sándor Bátori

Biochemical and Pharmacological Characterization of 2-(9-(2-Piperidinoethoxy)-4-oxo-4 H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-methylethyl)-6-methoxy-1,2-benzisothiazol-3(2 H)-one-1,1-dioxide (SSR69071), a Novel, Orally Active Elastase Inhibitor

Zoltán Kapui, Márton Varga, Katalin Urbán-Szabó et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 39 citations

Prolyl Oligopeptidase Inhibition by<i>N</i>-Acyl-pro-pyrrolidine-type Molecules

Károly Kánai, Péter Arányi, Zsolt Böcskei et al. · Journal of Medicinal Chemistry · 2008 · 39 citations · Full text

Bioorganic Chemistry, Molecular Biology, Prolyl Oligopeptidase +18

Regioselectivity in methylation and phenylation of the zwitterionic pyrido[2,1‐<i>f]‐as</i>‐triazinium‐1‐ and 3‐olates and thiolates

Sándor Bátori, András Messmer · Journal of Heterocyclic Chemistry · 1988 · 27 citations

Derivative (Chemistry), Biochemistry, Natural Sciences +9

Reactions of 2-dialkylamino-3H-azepines with oxidants and electrophiles

Sándor Bátori, R. Gompper, Josef C. Meier et al. · Tetrahedron · 1988 · 25 citations

Organic Chemistry, Electrosynthesis, Synthetic Chemistry +1

Synthesis and regiospecificity in methylation of pyrido[1,2‐<i>a</i>]pyrazinium‐1‐ and 3‐olates and pyrido[1,2‐<i>b</i>]pyridazinium‐2‐ and 4‐olates

Sándor Bátori, András Messmer · Journal of Heterocyclic Chemistry · 1990 · 24 citations

Chemical Engineering, Diversity Oriented Synthesis, Derivatives +13